Clinical Trial Update: First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial evaluating OT-A201 in patients with selected hematologic malignancies and solid tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• OT-A201

Snippet

Sponsor: Onward Therapeutics | Conditions: Hematological Malignancy, Solid Tumor | Phase 1 | Status: RECRUITING